Menu Menu Menu
Nice Insight Research
Content Menu
Menu Menu Menu
To Top

Search By Topic

Logistics

19 Articles available
Clinical Trials

Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile

PAP-Q2-18-CL-002
Controlled Nucleation

Achieving Controlled Nucleation During Aseptic Lyophilization

PAP-Q2-18-CL-018
Logistics

Marken Delivering New Hybrid Service

PR-M09-17-NI-002
Clinical Logistics

Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines

PAP-Q3-17-CL-007
Design Logic

Marken: Stronger Than Ever

PAP-Q3-17-DL-001
CDMO

The CDMO and the International Supply Chain: How Global and Local Relationships are Guiding Sponsors and Providers

PAP-Q3-17-FA-001
Roundtable

Q: How important are international partnerships (with sponsor firms, service providers, engineering firms, equipment vendors, raw material suppliers, etc.) to your success?

PAP-Q3-17-RT-001
Logistics

Bain Capital, Cinven and STADA Make a Deal

PAO-M04-17-NI-016
Supply Chain

Increasing Productivity and Profitability

Pamela J. Roach, CEO, Breakthrough Marketing Technology LLC

PTV-M01-17-NS-006
Supply Chain

Direct to Patient Logistics and Technology

Paddy Hanlon, Vice President, Commercial Operations East Coast & Canada, Marken

PTV-M01-17-NS-003
Biologics

GermFree Bio Introduces Mobile GMP Cleanroom Platform

PAO-M04-17-NI-009
Logistics

Merck and Bristol-Myers Squibb Extend Partnerships with Incyte

PAO-M04-17-NI-005
Supply Chain

Keeping the Chain Going

PAP-Q1-17-FA-007
Supply Chain

Dissolving Boundaries in Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

PAP-Q1-17-CL-011
CDMO

Supply Chain Management and the Importance of Security of Supply

PAP-Q04-16-CL-002
Aggregation

Track & Trace Systems for Serialization and Aggregation

PAP-Q03-16-CL-012
Supply Chain

Clinical Logistics – Meeting the 21st Century Cures Challenge

PAP-Q1-16-CL-003
Biologics

Logistics Providers Strive to Fulfill Biopharma Needs – Specialty Companies Offer Advantages, but Get a Bad Rap on Price

LSL-M11-14-NI-002
Biologics

Outsourcing To CROs And CMOs In Emerging Markets In 2014

CIO-M01-14-NI-002
×